Sipuleucel-T Completed Phase 2 Trials for Neoplasms of the Prostate / Prostate Cancer

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT01477749Sipuleucel-T Manufacturing Demonstration Study